Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up

Francisco Vega, Catalina Amador, Amy Chadburn, Eric D. Hsi, Graham Slack, L. Jeffrey Medeiros, Andrew L. Feldman

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


Peripheral T-cell lymphomas are a heterogeneous, and usually aggressive, group of mature T-cell neoplasms with overlapping clinical, morphologic and immunologic features. A large subset of these neoplasms remains unclassifiable with current diagnostic methods (“not otherwise specified”). Genetic profiling and other molecular tools have emerged as widely applied and transformative technologies for discerning the biology of lymphomas and other hematopoietic neoplasms. Although the application of these technologies to peripheral T-cell lymphomas has lagged behind B-cell lymphomas and other cancers, molecular profiling has provided novel prognostic and diagnostic markers as well as an opportunity to understand the biologic mechanisms involved in the pathogenesis of these neoplasms. Some biomarkers are more prevalent in specific T-cell lymphoma subsets and are being used currently in the diagnosis and/or risk stratification of patients with peripheral T-cell lymphomas. Other biomarkers, while promising, need to be validated in larger clinical studies. In this review, we present a summary of our current understanding of the molecular profiles of the major types of peripheral T-cell lymphoma. We particularly focus on the use of biomarkers, including those that can be detected by conventional immunohistochemical studies and those that contribute to the diagnosis, classification, or risk stratification of these neoplasms.

Original languageEnglish (US)
Pages (from-to)306-318
Number of pages13
JournalModern Pathology
Issue number3
StatePublished - Mar 2022

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up'. Together they form a unique fingerprint.

Cite this